hsCRP and Inflammation: The Invisible Cardiovascular Threat

The 2018 CANTOS trial changed cardiovascular medicine. Researchers gave canakinumab, a drug that blocks the inflammatory cytokine IL-1β, to patients who had already had heart attacks and had elevated hsCRP but normal LDL cholesterol. The drug reduced their recurrent cardiovascular events by 15% — with no effect on LDL whatsoever. The result was definitive: inflammation drives heart disease as an independent causal factor, not just a marker.

In the years since, hsCRP has moved from "interesting to measure" to "should be on every serious cardiovascular panel." Most men haven't had it measured. That's a gap in the assessment.

What hsCRP Actually Measures

C-reactive protein is made by your liver in response to inflammation. It rises sharply during acute infections (can reach 50-200+ mg/L during significant illness) and chronically elevates with ongoing low-grade inflammation from dozens of sources.

"High-sensitivity" CRP uses a more precise assay that can measure the low levels (0.5-10 mg/L) relevant to chronic inflammation assessment. Standard CRP tests can't detect variation at these low levels.

hsCRP reference ranges:

• Under 1 mg/L: Low cardiovascular risk
• 1-3 mg/L: Moderate risk
• Over 3 mg/L: High risk
• Over 10 mg/L: Suggests acute infection or significant inflammatory condition — investigate, don't assume it's just "chronic inflammation"

Why Inflammation Matters for Atherosclerosis

Atherosclerotic plaque isn't just cholesterol accumulation. It's an active inflammatory process. LDL particles penetrate the arterial wall, get oxidized, attract immune cells (macrophages), which engulf the oxidized LDL and become foam cells. Foam cells accumulate, release more inflammatory signals, and the process cascades.

In this model, systemic inflammation does two things:

1. Makes the arterial environment more receptive to lipoprotein retention and oxidation
2. Accelerates the inflammatory cascade within plaques, making them more likely to rupture (causing heart attacks)

A man with normal LDL but high inflammation is driving plaque formation through the inflammatory mechanism despite lower lipid input. A man with high LDL and low inflammation has different risk dynamics. Combining both measurements gives a more complete picture.

What Drives Elevated hsCRP

Sources of chronic low-grade inflammation:

• Visceral adiposity. Fat cells around organs produce inflammatory cytokines. Obesity is the single biggest driver of chronically elevated hsCRP in middle-aged adults.
• Metabolic syndrome and insulin resistance. Chronic hyperinsulinemia drives inflammation.
• Poor sleep / sleep apnea. Sleep disruption chronically elevates inflammatory markers.
• Smoking. Including vaping — obvious and substantial.
• Periodontal disease. Chronic low-grade gum infection is a surprisingly common hsCRP driver, often missed.
• Chronic alcohol consumption. Especially heavier drinking.
• Diet high in processed foods / low fiber. Gut microbiome dysregulation and low-grade systemic inflammation.
• Sedentary lifestyle. Physical inactivity independently raises inflammatory markers.
• Chronic stress. Sustained cortisol and sympathetic activation.
• Autoimmune conditions. Rheumatoid arthritis, lupus, inflammatory bowel disease, psoriasis.
• Other chronic infections. H. pylori, chronic hepatitis, chronic sinusitis.

hsCRP isn't specific — it can't tell you which source is the problem. But chronically elevated hsCRP in an otherwise healthy-appearing man deserves investigation.

The Acute Illness Caveat

hsCRP rises dramatically with any infection or significant inflammatory event. A cold, dental procedure, minor injury, or intense exercise can spike it for days. Testing hsCRP during or shortly after any of these produces misleading numbers.

For meaningful measurement:

• Be free of acute illness for at least 2 weeks
• No major physical trauma or surgery recently
• Not immediately post-vaccine (within 1-2 weeks)
• Not within 24 hours of intense exercise

One elevated hsCRP in isolation is low information. A pattern of chronically elevated levels across multiple measurements is meaningful.

What Lowers hsCRP

Interventions with the best evidence for reducing chronic inflammation:

Weight loss, particularly visceral fat reduction. Single largest lever. 10% body weight loss typically reduces hsCRP 20-30%.

Regular aerobic exercise. Consistent moderate-intensity exercise reduces inflammatory markers even without weight loss. 150+ minutes per week of Zone 2 cardio is the benchmark.

Strength training. Similar independent effect to cardio, modest additional benefit when combined.

Mediterranean-style diet. Olive oil, fish, vegetables, nuts, whole grains, legumes. Solid evidence for modest anti-inflammatory effects across trials.

Increased omega-3 intake. From fatty fish or supplementation. Modest effect on hsCRP; larger effect on related inflammatory markers.

Sleep optimization. Getting from 6 hours to 7.5 hours consistently can lower hsCRP substantially.

Alcohol reduction. Chronic drinking raises inflammation; cutting back reduces it.

Smoking cessation. hsCRP drops within weeks of quitting.

Dental hygiene. Treating periodontitis reduces hsCRP measurably. Get regular cleanings.

Stress reduction. Meaningful chronic stress reduction (via lifestyle, therapy, meditation) reduces inflammatory markers.

Statins. Reduce hsCRP independently of their lipid effects, part of why they work so well for cardiovascular prevention.

Metformin. Has anti-inflammatory effects beyond glycemic control.

What Doesn't Work Well

Turmeric/curcumin at typical supplement doses: weak and inconsistent evidence for measurable hsCRP reduction in men without specific inflammatory conditions.

Fish oil at modest doses (1 g): minor effect; higher doses (2-4 g EPA+DHA) show more consistent reduction.

"Anti-inflammatory diets" marketed online: most effects, where they exist, come from the Mediterranean-style core principles rather than specific exotic ingredients.

Zero-calorie supplements promising dramatic inflammation reduction: virtually always overselling their evidence.

When to Worry

Persistently elevated hsCRP (over 5 mg/L) in a man without obvious explanation (obesity, smoking, etc.) warrants investigation for:

• Hidden chronic infection (dental, sinus, prostatitis)
• Subclinical autoimmune disease
• Occult cancer (rare but possible)
• Undiagnosed inflammatory bowel disease
• Sleep apnea

Don't dismiss persistently high inflammation as "just aging" or "genetics." It's usually telling you about something specific that can be identified.

Integration with Cardiovascular Assessment

hsCRP is most useful alongside other cardiovascular markers, not as a standalone:

• Normal ApoB + normal hsCRP: low cardiovascular risk
• Elevated ApoB + normal hsCRP: traditional lipid-driven risk
• Normal ApoB + elevated hsCRP: inflammation-driven risk
• Elevated ApoB + elevated hsCRP: compound risk, aggressive management warranted

The CANTOS findings suggest that even normal-LDL patients with elevated inflammation benefit from addressing inflammation. The emerging therapeutic landscape includes several IL-1 and IL-6 pathway drugs being studied for cardiovascular prevention.

The Cost and How to Get It

hsCRP testing is cheap — $20-40 direct-to-consumer. Usually requires specific request; standard panels often include a non-high-sensitivity CRP that won't detect the relevant levels.

Through insurance with physician order, routinely covered. Code 86140.

Add it to your annual blood panel alongside ApoB, Lp(a), fasting insulin, and hormone markers. The cost is trivial relative to the information.

The Practical View

Your cardiovascular risk isn't just about lipids. Inflammation is an independent driver that you can measure and address. hsCRP is the cheapest, most accessible way to track it. If yours is elevated, identify why and address the underlying cause. If yours is low and stable, that's real information — and real reassurance — that your inflammatory environment isn't actively accelerating disease.

Talk to your doctor about whether addressing inflammation should be part of your cardiovascular strategy. For most men with elevated hsCRP, the interventions are lifestyle-focused and beneficial beyond cardiovascular health alone.